Results 1-332 of 332 (Search time: 0.029 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12022Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized TrialCheng P.-N.; CHUN-JEN LIU ; Chen C.-Y.; Tseng K.-C.; Lo C.-C.; Peng C.-Y.; Lin C.-L.; Chiu H.-C.; Chiu Y.-C.; Chen P.-J.Clinical Gastroenterology and Hepatology20
22022Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarateChang, Huai-Lung; Wen, Wan-Hsin; CHIEN-NAN LEE ; Chiu, Yu-En; CHUN-JEN LIU ; Chang, Mei-Hwei; Lin, Lung-Huang; HUEY-LING CHEN Journal of Viral Hepatitis11
32021Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; CHUN-JEN LIU ; Kao J.-H.Hepatology International00
42021Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanCheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; CHUN-JEN LIU ; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigatorsInfectious Diseases and Therapy21
52021Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanLiu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H.Hepatology International67
62021Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort studyPapatheodoridi M.; Su T.-H.; Hadziyannis E.; Liao C.-H.; Orfanidou Α.; Yang H.-C.; Zachou K.; CHUN-JEN LIU ; Kourikou A.; Gatselis N.; Manolakopoulos S.; Dalekos G.; Kao J.-H.; Hadziyannis S.; Papatheodoridis G.V.Liver International43
72021Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatmentLiu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; CHUN-JEN LIU ; Su T.-H.; Tseng T.-C.; Chen P.-J.; Kao J.-H.Alimentary Pharmacology and Therapeutics43
82021Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in TaiwanHsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; CHUN-JEN LIU ; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigatorsJournal of Gastroenterology and Hepatology (Australia)10
92021Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant articleLin Y.-C.; Wang H.-Y.; Kuo Y.-C.; Chen M.-J.; Wu M.-S.; CHUN-JEN LIU ; Yang H.W.; Shih S.-C.; Yu L.-Y.; Ko H.-J.; Yeh H.-I.; Hu K.-C.Medicine00
102021Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in TaiwanCheng P.-N.; Chen C.-Y.; Yu M.-L.; Lin C.-C.; Lin C.-Y.; Peng C.-Y.; Tseng K.-C.; Lo C.-C.; Tseng I.-H.; CHUN-JEN LIU Journal of Microbiology, Immunology and Infection32
112021Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconvertersLin S.-R.; Yang T.-Y.; Peng C.-Y.; Lin Y.-Y.; Dai C.-Y.; Wang H.-Y.; Su T.-H.; Tseng T.-C.; Liu I.-J.; Cheng H.-R.; Shen Y.-C.; Wu F.-Y.; CHUN-JEN LIU ; Chen D.-S.; Chen P.-J.; Yang H.-C.; Kao J.-H.JHEP Reports65
122021Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in TaiwanChen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; Lin H.-C.; Yu M.-L.Liver International1615
132021Mining Gut Microbiota From Bariatric Surgery for MAFLDWu W.-K.; Chen Y.-H.; Lee P.-C.; Yang P.-J.; Chang C.-C.; Liu K.-L.; Hsu C.-C.; Huang C.-C.; Chuang H.-L.; Sheen L.-Y.; CHUN-JEN LIU ; Wu M.-S.Frontiers in Endocrinology34
142021Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factorsYu M.-W.; Lin C.-L.; CHUN-JEN LIU ; Huang Y.-W.; Hu J.-T.; Wu W.-J.; Wu C.-F.Journal of the Formosan Medical Association21
152021Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agentsHuang S.-C.; Cheng P.-N.; Liu C.-H.; Yang H.-C.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; CHUN-JEN LIU Journal of the Formosan Medical Association23
162021Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; CHUN-JEN LIU ; Yu M.-L.Hepatology International00
172021Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in TaiwanHong C.-M.; Lin Y.-Y.; CHUN-JEN LIU ; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; Kao J.-H.; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J.Viruses10
182021Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in TaiwanHuang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Lin C.-L.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; CHUN-JEN LIU ; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Kao J.-H.; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.Scientific Reports31
192021Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCVCHUN-JEN LIU ; Chen P.-J.Liver International54
202021Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosisSu T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; CHUN-JEN LIU ; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Kao J.-H.Journal of the Formosan Medical Association44
212021Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosisLiu C.-H.; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU ; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H.Clinical and Molecular Hepatology14
222021Molecular mechanisms and animal models of HBV-related hepatocellular carcinoma: With emphasis on metastatic tumor antigen 1Li Y.-T.; Wu H.-L.; CHUN-JEN LIU International Journal of Molecular Sciences11
232021Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patientsCheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; CHUN-JEN LIU ; Kao J.-H.Hepatology International11
242021Investigating the prevalence and clinical effects of hepatitis delta viral infection in TaiwanLee W.-C.; Chen T.-K.; Han H.-F.; Lin Y.-C.; Hwang Y.-M.; Kao J.-H.; Chen P.-J.; CHUN-JEN LIU Journal of Microbiology, Immunology and Infection01
252021Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapyLiu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; CHUN-JEN LIU ; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H.Journal of Viral Hepatitis34
262021Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTseng T.-C.; CHUN-JEN LIU ; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.Alimentary Pharmacology and Therapeutics1212
272021Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of TaiwanShao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; CHUN-JEN LIU ; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy GroupJournal of the Formosan Medical Association3235
282021Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; Kao J.-H.; CHUN-JEN LIU ; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L.Clinical Gastroenterology and Hepatology33
292021Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU ; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y.Journal of Gastroenterology and Hepatology (Australia)36
302021Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver diseaseHuang S.-C.; Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; CHUN-JEN LIU Gut and Liver1920
312020Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisSu T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; CHUN-JEN LIU ; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases67
322020Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; CHUN-JEN LIU ; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study GroupOpen Forum Infectious Diseases00
332020Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trialsAsahina Y.; CHUN-JEN LIU ; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; Chen P.-J.; Enomoto N.Hepatology Research66
342020Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinomaHuang B.-Y.; Tsai M.-R.; Hsu J.-K.; Lin C.-Y.; Lin C.-L.; Hu J.-T.; Huang Y.-W.; CHUN-JEN LIU ; Wu W.-J.; Wu C.-F.; Sung F.-Y.; Chen P.-J.; Liang H.-J.; Lin S.-M.; Yu M.-W.Molecular Carcinogenesis22
352020Effects and safety of body positioning on back pain after transcatheter arterial chemoembolization in people with hepatocellular carcinoma: A randomized controlled studyChang K.-T.; CHUN-JEN LIU ; Tsai H.-T.; Hsu T.-P.; Chen P.-T.; Hu S.H.International Journal of Nursing Studies22
362020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in TaiwanLiu C.-H.; CHUN-JEN LIU ; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Liver International1615
372020HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTseng T.-C.; CHUN-JEN LIU ; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Hepatology2120
382020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; CHUN-JEN LIU ; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Liver Cancer119
392020Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairmentLiu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H.Gut1517
402020Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base EditingYang Y.-C.; Chen Y.-H.; Kao J.-H.; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Yang H.-C.Molecular Therapy - Nucleic Acids4333
4120202020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsYu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.Journal of the Formosan Medical Association4439
422020Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancerSu T.-H.; Tseng T.-C.; CHUN-JEN LIU ; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.International Journal of Cancer33
432020Relationship between serum gamma-glutamyl transferase level and colorectal adenomaHong T.-C.; Yang H.-C.; Chen C.-L.; Kao J.-H.; CHUN-JEN LIU ; Chen M.-J.; Wang H.-Y.; Kuo Y.-C.; Yu L.-Y.; Hu K.-C.PLoS ONE11
442020Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in TaiwanLiu C.-H.; Su T.-H.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of the Formosan Medical Association23
452020Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU ; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L.The American journal of gastroenterology1513
462020Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataHong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; CHUN-JEN LIU Journal of Microbiology, Immunology and Infection1414
472020Hepatitis C virus and hepatitis B virus co-infectionShih Y.-F.; CHUN-JEN LIU Viruses1414
482020Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarateWen W.-H.; HUEY-LING CHEN ; TIFFANY TING-FANG SHIH ; JIA-FENG WU ; YEN-HSUAN NI ; CHIEN-NAN LEE ; Zhao L.-L.; Lai M.-W.; Mu S.-C.; YI-CHING TUNG ; HONG-YUAN HSU ; MEI-HWEI CHANG ; MING-KWANG SHYU ; HSIAO-LIN HWA ; Su Y.N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; YU-CHUN CHIU ; KAI-CHI CHANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Chen D.S.; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)Journal of Hepatology1817
4920202020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationYu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.Journal of the Formosan Medical Association3938
502020Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfectionCheng X.; Uchida T.; Xia Y.; Umarova R.; CHUN-JEN LIU ; Chen P.-J.; Gaggar A.; Suri V.; M?cke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J.Journal of Clinical Investigation2929
512020Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antiviralsLiu C.-H.; Lee M.-H.; Lin J.-W.; CHUN-JEN LIU ; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Hepatology3032
522020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentLiu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; CHUN-JEN LIU ; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Viral Hepatitis1515
532020Limited drug–drug interaction of elbasvir/grazoprevir for chronic hepatitis CCHUN-JEN LIU ; Tseng K.-C.; Lo C.-C.; Tseng I.-H.; Cheng P.-N.Journal of the Formosan Medical Association22
542020High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapyChang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; CHUN-JEN LIU ; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases44
552020Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in TaiwanSu H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; CHUN-JEN LIU Journal of the Formosan Medical Association97
562020Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysisLiu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Scientific Reports44
572020Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges aheadCHUN-JEN LIU ; Chen P.-J.Viruses1312
582020Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritisHsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU ; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y.Scientific Reports34
592019A simple non-invasive test for ruling out cirrhosis in chronic hepatitis BTseng T.-C.; Shih Y.-F.; CHUN-JEN LIU The Lancet Gastroenterology and Hepatology00
602019Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaqueYu L.-Y.; Hu K.-C.; CHUN-JEN LIU ; Hung C.-L.; Bair M.-J.; Chen M.-J.; Wang H.-Y.; Wu M.-S.; Shih S.-C.; Liu C.-C.Medicine55
612019Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort StudyHu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu C.-C.; Su T.-H.; Liao W.-C.; Chen C.-L.; CHUN-JEN LIU ; Shih S.-C.Clinical Infectious Diseases1213
622019Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infectionSu T.-H.; CHUN-JEN LIU ; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.Alimentary Pharmacology and Therapeutics98
632019Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysisLiu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; CHUN-JEN LIU ; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)66
642019Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infectionLiu C.-H.; Su T.-H.; CHUN-JEN LIU ; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)1313
652019Profile and value of FIB-4 in patients with dual chronic hepatitis C and BCHUN-JEN LIU ; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)87
662019Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothersKAI-CHI CHANG ; MEI-HWEI CHANG ; CHIEN-NAN LEE ; Chang C.-H.; JIA-FENG WU ; YEN-HSUAN NI ; Wen W.-H.; MING-KWANG SHYU ; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; CHUN-JEN LIU ; DING-SHINN CHEN ; Lin L.-H.; HUEY-LING CHEN ; HSIAO-LIN HWA ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; HONG-YUAN HSU ; YU-CHUN CHIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Zhao L.-L.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)Alimentary Pharmacology and Therapeutics1416
672019Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine AminotransferaseWang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; CHUN-JEN LIU ; Yang Y.-C.; Chen P.-J.; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; Yu M.-W.Hepatology1515
682019Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular CarcinomaLi Y.-T.; Wu H.-L.; Kao J.-H.; Cheng H.-R.; Ho M.-C.; Wang C.-C.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU Hepatology43
692019Taiwan consensus statement on the management of chronic hepatitis BChien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; CHUN-JEN LIU ; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; Chen P.-J.; Liaw Y.-F.Journal of the Formosan Medical Association3130
702019Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myelomaSu T.-H.; CHUN-JEN LIU ; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.Alimentary Pharmacology and Therapeutics2121
712019Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of ParkinsonismSu T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; CHUN-JEN LIU ; Chen C.-L.; Kao J.-H.Movement Disorders119
722019NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingSu T.-H.; Liao S.-H.; Hong C.-M.; CHUN-JEN LIU ; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)22
732019High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral LoadTseng T.-C.; CHUN-JEN LIU ; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Gastroenterology6555
742019Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsYu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; Kao J.-H.; Chuang W.-L.; Chen P.-J.; Chen D.-S.Journal of the Formosan Medical Association98
752018Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanLiu C.-H.; CHUN-JEN LIU ; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.PLoS ONE88
762018Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational studyLiu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; CHUN-JEN LIU ; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.Scientific Reports2220
772018The Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groupsChitturi S.; Wong V.W.-S.; Chan W.-K.; Wong G.L.-H.; Wong S.K.-H.; Sollano J.; Ni Y.-H.; CHUN-JEN LIU ; Lin Y.-C.; Lesmana L.A.; Kim S.U.; Hashimoto E.; Hamaguchi M.; Goh K.-L.; Fan J.; Duseja A.; Dan Y.Y.; Chawla Y.; Farrell G.; Chan H.L.-Y.Journal of Gastroenterology and Hepatology (Australia)8374
782018Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessmentWong V.W.-S.; Chan W.-K.; Chitturi S.; Chawla Y.; Dan Y.Y.; Duseja A.; Fan J.; Goh K.-L.; Hamaguchi M.; Hashimoto E.; Kim S.U.; Lesmana L.A.; Lin Y.-C.; CHUN-JEN LIU ; Ni Y.-H.; Sollano J.; Wong S.K.-H.; Wong G.L.-H.; Chan H.L.-Y.; Farrell G.Journal of Gastroenterology and Hepatology (Australia)235206
792018Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVCHUN-JEN LIU ; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; Chen P.-J.Gastroenterology7574
802018Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanHsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; Chen P.-J.; CHUN-JEN LIU ; Yu M.-L.Journal of the Formosan Medical Association54
812018Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenomaKuo Y.-C.; Shih S.-C.; Yu L.-Y.; Wu M.-S.; Su T.-H.; CHUN-JEN LIU ; Hu K.-C.Helicobacter10
822018Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis BPapatheodoridis G.V.; Manolakopoulos S.; Su T.-H.; Siakavellas S.; CHUN-JEN LIU ; Kourikou A.; Yang H.-C.; Kao J.-H.Hepatology3637
832018Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapySu T.-H.; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Radiology88
842018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; CHUN-JEN LIU ; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics1717
852018Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfectionLiu C.-H.; Sun H.-Y.; CHUN-JEN LIU ; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.Alimentary Pharmacology and Therapeutics2120
862018Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanLiu C.-H.; CHUN-JEN LIU ; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)2423
872018Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus InfectionLiu C.-H.; Chen Y.-S.; Wang S.-S.; CHUN-JEN LIU ; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.Clinical Infectious Diseases2219
882018A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patientsLiu C.-H.; CHUN-JEN LIU ; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.Journal of Gastroenterology and Hepatology (Australia)1213
892018Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir TherapySu T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU ; Kao J.-H.Journal of Infectious Diseases4343
902017Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaqueHu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; Su T.-H.; Chen C.-L.; CHUN-JEN LIU ; Shih S.-C.Oncotarget1414
912017Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C PatientsLee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; CHUN-JEN LIU ; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J.Scientific Reports1614
922017Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infectionLiu C.-H.; CHUN-JEN LIU ; Su T.-H.; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Open Forum Infectious Diseases3836
932017Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosisSu T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; CHUN-JEN LIU ; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.Scientific Reports98
942017Combination therapy for chronic hepatitis B: Current updates and perspectivesSu T.-H.; CHUN-JEN LIU Gut and Liver1715
952017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; CHUN-JEN LIU ; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology3432
962017Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-upChen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; CHUN-JEN LIU Journal of the Formosan Medical Association109
972017Synergistic effect of hyperglycemia and Helicobacter pylori infection status on colorectal adenoma riskHu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu S.-C.; Liu C.-C.; Su T.-H.; Chen C.-L.; CHUN-JEN LIU ; Shih S.-C.Journal of Clinical Endocrinology and Metabolism1716
982017Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved responseHong C.-M.; CHUN-JEN LIU ; Yeh S.-H.; Chen P.-J.Journal of the Formosan Medical Association43
992017Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis BYang H.-C.; Shih Y.-F.; CHUN-JEN LIU Journal of Infectious Diseases76
1002017Mother-to-infant transmission of hepatitis B virus: challenges and perspectivesShih Y.-F.; CHUN-JEN LIU Hepatology International1316
1012017NOhep: Toward Global Control of Hepatitis B Virus Infection - An IntroductionCHUN-JEN LIU ; Kao J.-H.Journal of Infectious Diseases44
1022017Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriersKao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; CHUN-JEN LIU ; Huang C.-J.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Yu M.-W.Molecular Carcinogenesis1414
1032017Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort StudyYu M.-W.; Lin C.-L.; CHUN-JEN LIU ; Yang S.-H.; Tseng Y.-L.; Wu C.-F.Gastroenterology9799
1042016How Does Aging Affect Presentation and Management of Biliary Stones?Hu K.-C.; Chu C.-H.; Wang H.-Y.; Chang W.-H.; Lin S.-C.; Liu C.-C.; Liao W.-C.; CHUN-JEN LIU ; Wu M.-S.; Shih S.-C.Journal of the American Geriatrics Society45
1052016Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinomaSung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; CHUN-JEN LIU ; Chen P.; Lin S.-M.; Yu M.-W.Hepatology1212
1062016Associated factors and clinical implications of serum aminotransferase elevation in scrub typhusSu T.-H.; CHUN-JEN LIU ; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; Kao J.-H.Journal of Microbiology, Immunology and Infection33
1072016Perspectives on dual hepatitis B and C infection in TaiwanCHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Tseng T.-C.; Kao J.-H.Journal of the Formosan Medical Association1111
1082016Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failureShi X.; Zhu P.; Yan G.; CHUN-JEN LIU ; Zhang C.; Huang G.; Zhang Y.; Yan Z.; Wang Y.Journal of Viral Hepatitis910
1092016Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infectionYang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU ; Kao J.-H.Medicine (United States)1613
1102016Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateSarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; Chen P.J.; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; CHUN-JEN LIU ; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; Kao J.H.Hepatology International13921353
1112016Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma modelLi Y.-T.; CHUN-JEN LIU ; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Wu H.-L.Oncotarget44
1122016Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver CancerChang M.-H.; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lai M.-W.; Wu T.-C.; Wu S.-F.; Lee C.-M.; Yang S.-S.; Chu H.-C.; Wang T.-E.; Chen B.-W.; Chuang W.-L.; Soon M.-S.; Lin C.-Y.; Chiou S.-T.; Kuo H.-S.; Chen D.-S.; Yang Y.-J.; Lo G.-H.; Kong M.-S.; Wang P.-M.; Yang C.-C.; Chu C.-H.; Lin L.-H.; Chien R.-N.; Lee T.-H.; Yang K.-C.; Liao L.-Y.; Mo L.-R.; Liu J.-D.; Yang T.-H.; Lo C.-C.; Tsai M.-H.; Chou C.-H.; Cheng Y.-S.Gastroenterology137114
1132016Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patientsWu H.-L.; Hsiao T.-H.; Chen P.-J.; Wong S.-H.; Kao J.-H.; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; CHUN-JEN LIU Scientific Reports2221
1142016Asian consensus on the relationship between obesity and gastrointestinal and liver diseasesKoh J.C.; Loo W.M.; Goh K.L.; Sugano K.; Chan W.K.; Chiu W.Y.P.; Choi M.-G.; Gonlachanvit S.; Lee W.-J.; Lee W.J.J.; Lee Y.Y.; Lesmana L.A.; Li Y.-M.; CHUN-JEN LIU ; Matsuura B.; Nakajima A.; Ng E.K.W.; Sollano J.D.; Wong S.K.H.; Wong V.W.S.; Yang Y.; Ho K.Y.; Dan Y.Y.Journal of Gastroenterology and Hepatology (Australia)4037
1152016Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisYang H.-I.; Tseng T.-C.; Liu J.; Lee M.-H.; CHUN-JEN LIU ; Su T.-H.; Batrla-Utermann R.; Chan H.L.Y.; Kao J.-H.; Chen C.-J.Clinical Gastroenterology and Hepatology2117
1162016Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort studySu T.-H.; CHUN-JEN LIU ; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.Hepatology3129
1172016Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis CMah Y.-H.; Liu C.-H.; Chen C.-L.; Tseng T.-C.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of the Formosan Medical Association67
1182015Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort studyHuang Y.-W.; Wang T.-C.; Yang S.-S.; Lin S.-Y.; Fu S.-C.; Hu J.-T.; CHUN-JEN LIU ; Kao J.-H.; Chen D.-S.Alimentary Pharmacology and Therapeutics2121
1192015Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infectionSong L.-W.; Liu P.-G.; CHUN-JEN LIU ; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; Kao J.-H.; Chen D.-S.; Chen P.-J.; Xia N.-S.Clinical Microbiology and Infection7677
1202015Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infectionTseng T.-C.; CHUN-JEN LIU ; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics4240
1212015Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stagesCHUN-JEN LIU ; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)11
1222015Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyLiang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases76
1232015Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotypingLiu C.-H.; Liang C.-C.; CHUN-JEN LIU ; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Clinical Microbiology5251
1242015Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionSu T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; CHUN-JEN LIU ; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America5450
1252015Development of risk scoring system for stratifying population for hepatocellular carcinoma screeningHung Y.-C.; Lin C.-L.; CHUN-JEN LIU ; Hung H.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chuang S.-C.; Yu M.-W.Hepatology3233
1262015Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trialLiu C.-H.; Huang C.-F.; CHUN-JEN LIU ; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.Scientific Reports77
1272015Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized TrialLiu C.-H.; Huang C.-F.; CHUN-JEN LIU ; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.Scientific Reports88
1282015Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trialLiu C.-H.; CHUN-JEN LIU ; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.Gut3027
1292015Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTseng T.-C.; CHUN-JEN LIU ; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Gut8576
1302015Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patientsYang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; Hsu S.-J.; Lai H.-C.; Su C.-W.; CHUN-JEN LIU ; Peng C.-Y.; Yu M.-L.PLoS ONE85
1312015Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis BLin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; CHUN-JEN LIU ; Kao J.-H.Journal of Clinical Gastroenterology2530
1322015Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort StudyLiu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; CHUN-JEN LIU ; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.Scientific Reports1211
1332015Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionCheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU Hepatology International1311
1342015Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virusHUEY-LING CHEN ; CHIEN-NAN LEE ; Chang C.-H.; YEN-HSUAN NI ; MING-KWANG SHYU ; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; DING-SHINN CHEN ; KIN-WEI CHAN ; MEI-HWEI CHANG ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; JIA-FENG WU ; HONG-YUAN HSU ; CHUN-JEN LIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study)Hepatology185171
1352014Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriersLiu C.-C.; Wang Y.-H.; Chuang E.Y.; Tsai M.-H.; Chuang Y.-H.; Lin C.-L.; CHUN-JEN LIU ; Hsiao B.-Y.; Lin S.-M.; Liu L.-Y.; Yu M.-W.Molecular Carcinogenesis75
1362014Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortalityCHUN-JEN LIU ; Chu Y.-T.; Shau W.-Y.; Kuo R.N.; Chen P.-J.; Lai M.-S.Gut4037
1372014Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: A nationwide cohort studyYeh Y.-C.; CHUN-JEN LIU ; Kuo R.N.; Lai C.-L.; Shau W.-Y.; Chen P.-J.; Lai M.-S.PLoS ONE1212
1382014Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in TaiwanChen C.-L.; Yang W.-S.; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; CHUN-JEN LIU ; Kao J.-H.; Chen P.-J.; Chen D.-S.; Chen C.-J.Cancer Epidemiology Biomarkers and Prevention1716
1392014Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implicationsWu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen D.-S.; Chen P.-J.; CHUN-JEN LIU Journal of Gastroenterology and Hepatology (Australia)2723
1402014Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countriesDan Y.Y.; Wong J.B.; Hamid S.S.; Han K.-H.; Jia J.D.; CHUN-JEN LIU ; Piratvisuth T.; Lok A.S.F.; Lim S.G.Hepatology International108
1412014Clinical presentations of patients from different age cohorts with biliary tract stone diseasesHu K.-C.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Lin S.-C.; CHUN-JEN LIU ; Wu M.-S.; Shih S.-C.Journal of Gastroenterology and Hepatology (Australia)86
1422014Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyCheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU Liver International1211
1432014Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular diseaseHu K.-C.; Wang H.-Y.; Liu S.-C.; Liu C.-C.; Hung C.-L.; Bair M.-J.; CHUN-JEN LIU ; Wu M.-S.; Shih S.-C.World Journal of Gastroenterology2422
1442014Molecular mechanism and treatment of viral hepatitis-related liver fibrosisSu T.-H.; Kao J.-H.; CHUN-JEN LIU International Journal of Molecular Sciences5048
1452014Commentary: Treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-viralsWong V.W.-S.; CHUN-JEN LIU Alimentary Pharmacology and Therapeutics11
1462014Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrenceCHUN-JEN LIU ; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.World Journal of Gastroenterology4843
1472014The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivoLin S.-R.; Yang H.-C.; Kuo Y.-T.; CHUN-JEN LIU ; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; Kao J.-H.; Chen D.-S.; Chen P.-J.Molecular Therapy - Nucleic Acids302285
1482014Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapySu T.-H.; CHUN-JEN LIU ; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology1513
1492014Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Yu M.-W.PLoS ONE5625
1502014Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issuesCHUN-JEN LIU Journal of Gastroenterology and Hepatology (Australia)1815
1512014Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirinChen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.; CHUN-JEN LIU Journal of Gastroenterology and Hepatology (Australia)87
1522014Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTseng T.-C.; CHUN-JEN LIU ; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)118
1532014Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infectionCHUN-JEN LIU ; Chen P.-J.World Journal of Gastroenterology2119
1542013Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trialLiu C.-H.; Huang C.-F.; CHUN-JEN LIU ; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.Annals of Internal Medicine7874
1552013Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre studyDai C.-Y.; Tseng T.-C.; Wong G.L.H.; Huang J-F.; Wong V.W.S.; CHUN-JEN LIU ; Yu M.-L.; Chuang W.-L.; Kao J.-H.; Yuen Chan H.L.; Chen D.-S.Journal of Antimicrobial Chemotherapy1919
1562013Milder clinical manifestation of scrub typhus in Kinmen, TaiwanSu T.-H.; CHUN-JEN LIU ; Chen D.-S.; Kao J.-H.Journal of the Formosan Medical Association1915
1572013Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C InfectionSu T.-H.; CHUN-JEN LIU ; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; Chen P.-J.; Kao J.-H.; Chen D.-S.PLoS ONE2015
1582013Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patientsHsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology International55
1592013Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B ProgressionHuang C.-J.; Wu C.-F.; Lan C.-Y.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU ; Liu H.-F.; Yu M.-W.PLoS ONE1415
1602013Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis CSu T.-H.; Liu C.-H.; CHUN-JEN LIU ; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America5052
1612013Global perspective on the natural history of chronic hepatitis B: Role of hepatitis B virus genotypes A to JCHUN-JEN LIU ; Kao J.-H.Seminars in Liver Disease121114
1622013Treatment options for dual HCV/HBV coinfectionCHUN-JEN LIU ; Kao J.-H.Emerging Therapeutic Options for Hepatitis C00
1632013Transabdominal ultrasound finding and acute hepatocellular injury in different cohorts of elderly adults with and without common bile duct stonesHu K.-C.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Lin S.-C.; CHUN-JEN LIU ; Wu M.-S.; Shih S.-C.Journal of the American Geriatrics Society11
1642013Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-upYu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; Liu C.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Kao J.-H.; Su W.-W.; Lin C.-L.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU Hepatology6158
1652013Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B PatientsCheng H.-R.; CHUN-JEN LIU ; Tseng T.-C.; Su T.-H.; Yang H.-I.; Chen C.-J.; Kao J.-H.PLoS ONE4691
1662013Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patientsYuan Q.; Song L.-W.; CHUN-JEN LIU ; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; Kao J.-H.; Chen D.-S.; Chen P.-J.; Xia N.-S.Gut6058
1672013Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkersTseng T.-C.; CHUN-JEN LIU ; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases4241
1682013Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loadsTseng T.-C.; CHUN-JEN LIU ; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology186183
1692013Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and managementCHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology International4135
1702013Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversionYang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; CHUN-JEN LIU ; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology4137
1712013IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patientsHsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Antiviral Therapy108
1722012Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconvertersTseng T.-C.; CHUN-JEN LIU ; Chen C.-L.; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases4343
1732012Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapySheng W.-H.; Hung C.-C.; Chang S.-Y.; CHUN-JEN LIU ; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; Chen P.-J.; Chang S.-C.Clinical Infectious Diseases1312
1742012Treatment of hepatitis C virus infection: Past, present and futureCHUN-JEN LIU ; Chen D.-S.Chronic Hepatitis B and C: Basic Science to Clinical Applications00
1752012Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remissionLin C.-L.; Tseng T.-C.; Su T.-H.; CHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.Hepatology International11
1762012Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral loadTseng T.-C.; CHUN-JEN LIU ; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology117110
1772012Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis BPan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; Kao J.-H.; Tseng T.-C.; Liu C.-H.; Chen P.-J.; CHUN-JEN LIU ; Chen D.-S.Hepatology International1615
1782012Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-viralsCHUN-JEN LIU ; Hsu C.-S.; Kao J.-H.Journal of Internal Medicine of Taiwan1
1792012Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivationTseng T.-C.; CHUN-JEN LIU ; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases4242
1802012Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4)Liaw Y.-F.; Kao J.-H.; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M.Hepatology International1616
1812012Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirinLiu C.-H.; Liang C.-C.; CHUN-JEN LIU ; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Antiviral Therapy2122
1822012Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapyLiu C.-H.; Liang C.-C.; CHUN-JEN LIU ; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Antiviral Therapy4039
1832012High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV loadTseng T.-C.; CHUN-JEN LIU ; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Gastroenterology387357
1842012Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 updateLiaw Y.-F.; Kao J.-H.; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M.Hepatology International802762
1852012The risky body mass index ranges for significant hepatitis B viral load: A campus-based studyChiang C.-H.; Lai J.-S.; Sheu J.-C.; Yen L.-L.; CHUN-JEN LIU ; Huang K.-C.Obesity Research and Clinical Practice1313
1862012Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obeseCHUN-JEN LIU Journal of Gastroenterology and Hepatology (Australia)155142
1872012Impact of hepatitis B virus infection on metabolic profiles and modifying factorsHsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; CHUN-JEN LIU ; Chen C.-L.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Viral Hepatitis5652
1882012Influences of tobacco and alcohol use on hepatocellular carcinoma survivalShih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; CHUN-JEN LIU ; Lin C.-L.; Yu M.-W.International Journal of Cancer4743
1892012Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinomaKao J.-H.; CHUN-JEN LIU ; Jow G.-M.; Chen P.-J.; Chen D.-S.; Chen B.-F.Liver International3230
1902011The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back studySu T.-H.; Chen P.-J.; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; Kao J.-H.; Chen D.-S.; CHUN-JEN LIU Transfusion Medicine2925
1912011Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs CCHUN-JEN LIU ; Cheng H.-R.; Chen C.-L.; Chen T.-C.; Tseng T.-C.; Wang Z.-L.; Chen P.-J.; Liu C.-H.; Chen D.-S.; Kao J.-H.Journal of Viral Hepatitis2019
1922011Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohortChao L.-T.; Wu C.-F.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU ; Huang C.-J.; Tsai K.-S.; Yu M.-W.Carcinogenesis4541
1932011Community and personal risk factors for hepatitis C virus infection: A survey of 23 820 residents in Taiwan in 1991-2Lee M.-H.; Yang H.-I.; Jen C.-L.; Lu S.-N.; Yeh S.-H.; CHUN-JEN LIU ; You S.-L.; Sun C.-A.; Wang L.-Y.; Chen W.J.; Chen C.-J.Gut4647
1942011Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapyHsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; CHUN-JEN LIU ; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S.Proceedings of the National Academy of Sciences of the United States of America5654
1952011Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C virusesYeh M.-L.; Hung C.-H.; Huang J.-F.; CHUN-JEN LIU ; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; Kao J.-H.; Chuang W.-L.; Chen P.-J.; Chen D.-S.PLoS ONE1915
1962011Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathwayHuang H.-H.; Shih W.-L.; Li Y.-H.; Wu C.-F.; Chen P.-J.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W.Gut2121
1972011Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapyTseng T.-C.; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H.Antiviral Therapy7569
1982011Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patientsLiu C.-H.; Liang C.-C.; Huang K.-W.; CHUN-JEN LIU ; Chen S.-I.; Lin J.-W.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; Kao J.-H.Clinical Journal of the American Society of Nephrology6762
1992011HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infectionHsu S.-J.; Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU ; Chen C.-L.; Chen P.-J.; Chen D.-S.; Kao J.-H.Antiviral Therapy65
2002011Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in TaiwanMah Y.-H.; Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU ; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology International1210
2012011Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconvertersTseng T.; CHUN-JEN LIU ; Su T.; Wang C.; Chen C.; Chen P.; Chen D.; Kao J.Gastroenterology173161
2022011Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapyLiang C.-C.; Liu C.-H.; Lin Y.-L.; CHUN-JEN LIU ; Chiang B.-L.; Kao J.-H.Journal of Medical Virology107
2032010Metabolic syndrome on top of chronic hepatitis B: The more, the worse?Chang L.-C.; Chung C.-S.; CHUN-JEN LIU ; Kao J.-H.Gut11
2042010Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis BSu T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; CHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.Antiviral Therapy7572
2052010Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infectionHsu C.-S.; Liu C.-H.; CHUN-JEN LIU ; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)2729
2062010Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in TaiwanHuang Y.-W.; Liao Y.-T.; Chen W.; Chen C.-L.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Yang S.-S.; Kao J.-H.Genes and Immunity3934
2072010Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infectionHsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; CHUN-JEN LIU ; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology International1415
2082010HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C virusesYu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; CHUN-JEN LIU ; Chen D.-S.Journal of Infectious Diseases4137
2092010Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis BHuang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; Chen D.-S.; Yang S.-S.; Kao J.-H.Antiviral Therapy3737
2102010The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis CLiu C.-H.; Liang C.-C.; CHUN-JEN LIU ; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; Kao J.-H.Kidney International3031
2112010Hepatitis C virus infection and increased risk of cerebrovascular diseaseLee M.-H.; Yang H.-I.; Wang C.-H.; Jen C.-L.; Yeh S.-H.; CHUN-JEN LIU ; You S.-L.; Chen W.J.; Chen C.-J.Stroke118115
2122010Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis CLiu C.-H.; Liang C.-C.; CHUN-JEN LIU ; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.Clinical Infectious Diseases2925
2132010Implications of hepatitis B virus genomic variations on treatment outcomesTseng T.-C.; CHUN-JEN LIU ; Kao J.-H.Current Pharmacogenomics and Personalized Medicine50
2142010Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort studyLee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; Yeh S.-H.; CHUN-JEN LIU ; Chen P.-J.; You S.-L.; Wang L.-Y.; Chen W.J.; Chen C.-J.Journal of Clinical Oncology132125
2152009Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based studyShih W.-L.; Yu M.-W.; Chen P.-J.; Wu T.-W.; Lin C.-L.; CHUN-JEN LIU ; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F.European Journal of Human Genetics1715
2162009Patterns of managing chronic hepatitis B treatment-related drug resistance: A survey of physicians in Mainland China, South Korea, Taiwan, and ThailandChainuvati S.; Cheng J.; Hou J.L.; Hsu C.W.; Jia J.D.; Komolmit P.; Kwon S.Y.; Lee C.H.; Li H.; Li Y.; CHUN-JEN LIU ; Neo B.L.; Peng C.Y.; Tanwandee T.; Wongcharatrawee S.; Wu J.C.; Yu M.L.; Zhang X.X.Hepatology International98
2172009Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapyLiu C.-H.; Liang C.-C.; CHUN-JEN LIU ; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Gut2623
2182009High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infectionCHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Liu C.-H.; Chen C.-L.; Kao J.-H.; Chen D.-S.Hepatology International3229
2192009Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C VirusesCHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D.Gastroenterology170152
2202009Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapyTseng T.-C.; CHUN-JEN LIU ; Hsieh S.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.Digestive and Liver Disease33
2212009Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up studyChang M.-H.; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; Chen D.-S.Journal of the National Cancer Institute456393
2222009Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis BCHUN-JEN LIU ; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H.Journal of Infectious Diseases2520
2232009Dual chronic hepatitis B virus and hepatitis C virus infectionCHUN-JEN LIU ; Chen P.-J.; Chen D.-S.Hepatology International3937
2242009Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapyHsu C.-S.; Liu C.-H.; CHUN-JEN LIU ; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.Antiviral Therapy3330
2252009Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infectionHsu C.-S.; Liu C.-H.; CHUN-JEN LIU ; Wang C.-C.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology3634
2262009Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype CHsieh T.-H.; Tseng T.-C.; CHUN-JEN LIU ; Lai M.-Y.; Chen P.-J.; Hsieh H.-L.; Chen D.-S.; Kao J.-H.Antiviral Therapy3024
2272009Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosageCHUN-JEN LIU ; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.Journal of Hepatology125117
2282009Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levelsTseng T.-C.; CHUN-JEN LIU ; Wang C.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.Antiviral Therapy1612
2292009Hepatitis B Virus Core Variants Modify Natural Course of Viral Infection and Hepatocellular Carcinoma ProgressionSung F.; Jung C.; Wu C.; Lin C.; CHUN-JEN LIU ; Liaw Y.; Tsai K.; Yu M.Gastroenterology3334
2302009Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virusHuang Y.-W.; Hu C.-Y.; Chen C.-L.; Liao Y.-T.; CHUN-JEN LIU ; Lai M.-Y.; Chen P.-J.; Yang S.-S.; Hu J.-T.; Chen D.-S.; Kao J.-H.Journal of Medical Virology76
2312009Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinomaCHUN-JEN LIU ; Huang Y.-J.; Chen H.-L.; Lin H.-T.; Lin H.-L.; Kuo M.-L.; Huang J.-L.; Chen D.-S.; Chen P.-J.; Wu H.-L.Genes and Immunity45
2322008Viral hepatocarcinogenesis: From infection to cancerTan A.; Yeh S.-H.; CHUN-JEN LIU ; Cheung C.; Chen P.-J.Liver International9984
2332008Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in TaiwanChen C.; Yang HwaiI.; Yang W.; CHUN-JEN LIU ; Chen P.; You S.; Wang L.; Sun C.; Lu S.; Chen D.; Chen C.Gastroenterology430404
2342008Metabolic profiles in patients with chronic hepatitis C: A case-control studyHsu C.-S.; CHUN-JEN LIU ; Liu C.-H.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.Hepatology International2627
2352008Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infectionSu T.-H.; CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology00
2362008A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patientsTseng T.-C.; CHUN-JEN LIU ; Wang C.-C.; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Liver International1916
2372008Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosisWang C.-C.; Hsu C.-S.; CHUN-JEN LIU ; Kao J.-H.; Chen D.-S.Journal of Gastroenterology and Hepatology (Australia)8372
2382008Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosisLiu C.-H.; Hsu S.-J.; Liang C.-C.; Tsai F.-C.; Lin J.-W.; CHUN-JEN LIU ; Yang P.-M.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Kao J.-H.; Chen D.-S.Radiology2322
2392008Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutationsCHUN-JEN LIU ; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)55
2402008Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinomaChou Y.-C.; Yu M.-W.; Wu C.-F.; Yang S.-Y.; Lin C.-L.; CHUN-JEN LIU ; Shin W.-L.; Chen P.-J.; Liaw Y.-F.; Chen C.-J.Gut9895
2412008Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in menWu C.-F.; Yu M.-W.; Lin C.-L.; CHUN-JEN LIU ; Shih W.-L.; Tsai K.-S.; Chen C.-J.Carcinogenesis7369
2422008Body-mass index and progression of hepatitis B: A population-based cohort study in menYu M.-W.; Shih W.-L.; Lin C.-L.; CHUN-JEN LIU ; Jian J.-W.; Tsai K.-S.; Chen C.-J.Journal of Clinical Oncology9289
2432008Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trialLiu C.-H.; CHUN-JEN LIU ; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Clinical Infectious Diseases183170
2442008High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis CHsu C.-S.; CHUN-JEN LIU ; Liu C.-H.; Wang C.-C.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S.Liver International9489
2452008Genetic variability of hepatitis B virus and response to antiviral therapyCHUN-JEN LIU ; Kao J.-H.Antiviral Therapy3928
2462008Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysisShih Y.-H.; Yeh S.-H.; Chen P.-J.; Chou W.-P.; Wang H.-Y.; CHUN-JEN LIU ; Lu S.-F.; Chen D.-S.Antiviral Therapy95
2472008Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised studyLiu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; CHUN-JEN LIU ; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Kao J.-H.; Chen D.-S.Gut6560
2482008The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonismTsai Y.-H.; Kuang W.-F.; Lu T.-Y.; Kao J.-H.; Lai M.-Y.; CHUN-JEN LIU ; Chen P.-J.; Hwang L.-H.Journal of Hepatology1717
2492008Disease progression in a patient with nonalcoholic steatohepatitisTseng P.-H.; CHUN-JEN LIU ; Kao J.-H.; Shun C.-T.; Chen P.-J.; Chen D.-S.Journal of the Formosan Medical Association96
2502007Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinomaLin C.-L.; Chen J.-D.; CHUN-JEN LIU ; Lee P.-H.; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Journal of Viral Hepatitis2221
2512007Hepatitis B virus-related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factorsCHUN-JEN LIU ; Kao J.-H.Journal of the Chinese Medical Association680
2522007Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance IndexCHUN-JEN LIU ; Hsu S.; Lin J.; Hwang J.; Liu C.; Yang P.; Lai M.; Chen P.; Chen J.; Kao J.; Chen D.Clinical Gastroenterology and Hepatology2621
2532007Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patientsWang C.-C.; CHUN-JEN LIU ; Lai M.-Y.; Kao J.-H.; Chen D.-S.Liver International77
2542007Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinomaTsai F.-C.; CHUN-JEN LIU ; Chen C.-L.; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Journal of Viral Hepatitis1717
2552007Hepatitis B virus genotype: What should the clinician know?CHUN-JEN LIU ; Kao J.-H.Current Hepatitis Reports60
2562007Reply [2]Lin C.-L.; CHUN-JEN LIU ; Kao J.-H.Hepatology00
2572007Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in TaiwanTseng T.-C.; CHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Lin C.-L.; Kao J.-K.; Chen D.-S.Liver International1515
2582007Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]Tseng T.-C.; CHUN-JEN LIU ; Kao J.-H.American Journal of Gastroenterology11
2592007Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challengesLiu C.-H.; CHUN-JEN LIU ; Kao J.-H.Nephrology27
2602007Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in TaiwanHsu C.-S.; CHUN-JEN LIU ; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S.Intervirology1716
2612007Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levelsLin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; Yu M.-W.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.Hepatology9189
2622007High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug usersLin C.-.; CHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.Journal of Medical Virology1920
2632006Hemobilia associated with acute calculus cholecystitis successfully treated with endoscopic naso-biliary drainage and laparoscopic cholecystectomy - A case reportWang C.-C.; CHUN-JEN LIU ; Chen C.; Lin C.-H.Tzu Chi Medical Journal1
2642006Reply [3]CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.Journal of Hepatology00
2652006Reply [2]CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.Journal of Hepatology00
2662006Erratum: "Natural course and treatment of dual hepatitis virus and hepatitis C virus infections" (Journal of Formosan Medical Association (2005) vol. 104 (11) (783-791))CHUN-JEN LIU ; Liou J.-M.; Chen D.S.; Chen P.J.Journal of the Formosan Medical Association0
2672006Pegylated interferons for the treatment of chronic hepatitis B.CHUN-JEN LIU ; Kao J.H.Recent patents on anti-infective drug discovery50
2682006Clinical significance of occult hepatitis B virus infection cannot be overlooked [11]CHUN-JEN LIU ; Kao J.-H.; Chen D.-S.Clinical Infectious Diseases11
2692006Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than AnswersCHUN-JEN LIU ; Kao J.-H.; Chen D.-S.Gastroenterology77
2702006Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutantsCHUN-JEN LIU ; Kao J.-H.; Chen P.-J.; Chen T.-C.; Lin F.-Y.; Lai M.-Y.; Chen D.-S.Journal of Viral Hepatitis1412
2712006Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized studyCHUN-JEN LIU ; Lai M.-Y.; Chao Y.-C.; Liao L.-Y.; Yang S.-S.; Hsiao T.-J.; Hsieh T.-Y.; Lin C.-L.; Hu J.-T.; Chen C.-L.; Chen P.-J.; Kao J.-H.; Chen D.-S.Hepatology4035
2722006Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriersCHUN-JEN LIU ; Chen B.-F.; Chen P.-J.; Lai M.-Y.; Huang W.-L.; Kao J.-H.; Chen D.-S.Journal of Infectious Diseases152139
2732006High Prevalence and Mapping of Pre-S Deletion in Hepatitis B Virus Carriers With Progressive Liver DiseasesChen B.; CHUN-JEN LIU ; Jow G.; Chen P.; Kao J.; Chen D.Gastroenterology239229
2742006Mixed hepatitis B virus genotype infections: The more, the worse? [3]CHUN-JEN LIU ; Kao J.-H.; Chen D.-S.Hepatology75
2752006Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NATCHUN-JEN LIU ; Chen D.-S.; Chen P.-J.Journal of Clinical Virology10293
2762006Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case seriesHuang Y.-W.; CHUN-JEN LIU ; Lai M.-Y.; Lee P.-H.; Tsai M.-K.; Wang S.-S.; Lai M.-K.; Kao J.-H.Clinical Therapeutics76
2772006Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic areaShih W.-L.; Yu M.-W.; Chen P.-J.; Yeh S.-H.; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; Hsiao C.K.; Yang S.-Y.; Chen C.-J.Oncogene1714
2782006Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and CChen B.-F.; CHUN-JEN LIU ; Jow G.-M.; Chen P.-J.; Kao J.-H.; Chen D.-S.Journal of General Virology3228
2792006Natural course and treatment of hepatitis D virus infectionHsieh T.-H.; CHUN-JEN LIU ; Chen D.-S.; Chen P.-J.Journal of the Formosan Medical Association4237
2802006Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in TaiwanCHUN-JEN LIU ; Lo S.-C.; Kao J.-H.; Tseng P.-T.; Lai M.-Y.; Ni Y.-H.; Yeh S.-H.; Chen P.-J.; Chen D.-S.Journal of Hepatology9688
2812006Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis BCHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Lin F.-Y.; Wang T.; Kao J.-H.; Chen D.-S.Liver International3535
2822005Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in TaiwanMah Y.-H.; Kao J.-H.; CHUN-JEN LIU ; Chen C.-L.; Chen P.-J.; Lai M.-Y.; Chen D.-S.Liver International2116
2832005Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis CCHUN-JEN LIU ; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; Yang W.-S.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Journal of Hepatology6759
2842005Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis CCHUN-JEN LIU ; Jeng Y.-M.; Chen P.-J.; Lai M.-Y.; Yang H.-C.; Huang W.-L.; Kao J.-H.; Chen D.-S.Antiviral Therapy3331
2852005Natural course and treatment of dual hepatitis B virus and hepatitis C virus infectionsCHUN-JEN LIU ; Liou J.-M.; Chen D.-S.; Chen P.-J.Journal of the Formosan Medical Association4235
2862005Therapeutic implications of hepatitis B virus genotypesCHUN-JEN LIU ; Kao J.-H.; Chen D.-S.Liver International10782
2872005Subgenotypes of hepatitis B virus genotype C in Taiwan [3] (multiple letters)CHUN-JEN LIU ; Kao J.-H.; Chan H.L.-Y.Journal of Infectious Diseases44
2882005RNA interference-mediated control of hepatitis B virus and emergence of resistant mutantWu H.-L.; Huang L.-R.; Huang C.-C.; Lai H.-L.; CHUN-JEN LIU ; Huang Y.-T.; Hsu Y.-W.; Lu C.-Y.; Chen D.-S.; Chen P.-J.Gastroenterology9592
2892005Successful treatment of acute hepatitis A-associated hemophagocytic syndrome by intravenous immunoglobulinTai C.-M.; CHUN-JEN LIU ; Yao M.Journal of the Formosan Medical Association1112
2902005Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in menYu M.-W.; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; CHUN-JEN LIU ; Shih W.-L.; Kao J.-H.; Chen D.-S.; Chen C.-J.Journal of the National Cancer Institute478417
2912005Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in TaiwanLee S.-D.; Yu M.-L.; Cheng P.-N.; Lai M.-Y.; Chao Y.-C.; Hwang S.-J.; Chang W.-Y.; Chang T.-T.; Hsieh T.-Y.; CHUN-JEN LIU ; Chen D.-S.Journal of Viral Hepatitis7770
2922005Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinomaChen C.-C.; Yang S.-Y.; CHUN-JEN LIU ; Lin C.-L.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chen C.-J.; Yu M.-W.International Journal of Epidemiology9593
2932004Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversionCHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Journal of Medical Virology2421
2942004Lack of interferon sensitivity-determining region in the genome of hepatitis B virus genotype BaCHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Chen T.-C.; Wang H.-Y.; Huang W.-L.; Kao J.-H.; Chen D.-S.Antiviral Therapy98
2952004Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysisYeh S.-H.; Tsai C.-Y.; Kao J.-H.; CHUN-JEN LIU ; Kuo T.-J.; Lin M.-W.; Huang W.-L.; Lu S.-F.; Jih J.; Chen D.-S.; Chen P.-J.Journal of Hepatology190181
2962004A forgotten population with chronic hepatitis C infection: Subjects coinfected with hepatitis B virus [1]CHUN-JEN LIU ; Chen P.-J.; Chen D.-S.Hepatology1312
2972004Genotypic Dominance and Novel Recombinations in HBV Genotype B and C Co-Infected Intravenous Drug UsersChen B.-F.; Kao J.-H.; CHUN-JEN LIU ; Chen D.-S.; Chen P.-J.Journal of Medical Virology4438
2982004End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis BCHUN-JEN LIU ; Huang W.-L.; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.World Journal of Gastroenterology1412
2992004Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinomaChen J.-D.; CHUN-JEN LIU ; Lee P.-H.; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Clinical Gastroenterology and Hepatology4242
3002004Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbationCHUN-JEN LIU ; Kao J.-H.; Wang H.-Y.; Lai M.-Y.; Chen T.-C.; Chen P.-J.; Chen D.-S.Hepatology1717
3012004Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant HepatitisCHUN-JEN LIU ; Kao J.-H.; Lai M.-Y.; Chen P.-J.; Chen D.-S.Journal of Medical Virology3736
3022004High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug usersChen B.-F.; Chen P.-J.; Jow G.-M.; Sablon E.; CHUN-JEN LIU ; Chen D.-S.; Kao J.-H.Journal of Medical Virology4236
3032003Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related RiskYu M.-W.; Chang H.-C.; Chang S.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; Chen P.-J.; Lin S.-C.; Chen C.-J.Hepatology146122
3042003A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbationCHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chang C.-F.; Wu H.-L.; Shau W.-Y.; Chen D.-S.Gastroenterology5753
3052003Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinomaYu M.-W.; Yang S.-Y.; Pan I.-J.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Chen C.-J.Journal of the National Cancer Institute10594
3062003Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patientsCHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Jeng Y.-M.; Chen D.-S.Hepatology11493
3072003Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: A prospective studyCHUN-JEN LIU ; Chen P.-J.; Shau W.-Y.; Kao J.-H.; Lai M.-Y.; Chen D.-S.Liver International2221
3082003Molecular Assays for Hepatitis B Virus Infection [1]CHUN-JEN LIU ; Kao J.-H.; Chen D.-S.Hepatology55
3092002Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver diseaseCHUN-JEN LIU ; Kao J.-H.; Shau W.-Y.; Chen P.-J.; Lai M.-Y.; Chen D.-S.Journal of Medical Virology3935
3102002Molecular epidemiology of hepatitis B viral serotypes and genotypes in TaiwanCHUN-JEN LIU ; Kao J.H.; Chen P.J.; Lai M.Y.; Chen D.S.Journal of Biomedical Science3836
3112002Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern TaiwanYu M.-W.; Chang H.-C.; Chen P.-J.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J.International Journal of Epidemiology2727
3122002Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis BLin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Journal of Gastroenterology3737
3132002Hepatitis B viral genotypes and lamivudine resistance [1]Kao J.-H.; CHUN-JEN LIU ; Chen D.-S.Journal of Hepatology10184
3142002Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot studyKing J.K.; Yeh S.-H.; Lin M.-W.; CHUN-JEN LIU ; Lai M.-Y.; Kao J.-H.; Chen D.-S.; Chen P.-J.Hepatology6153
3152002Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in womenYu M.-W.; Yang Y.-C.; Yang S.-Y.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; Chen P.-J.; Lin S.-C.; Chen C.-J.Hepatology2622
3162001Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experienceCHUN-JEN LIU ; Lai M.-Y.; Lee P.-H.; Chou N.-K.; Chu S.-H.; Chen P.-J.; Kao J.-H.; Jen Y.-M.; Chen D.-S.Journal of Gastroenterology and Hepatology (Australia)3631
3172001Risk factors for ICU mortality in critically ill patientsChen Y.-C.; Lin S.-F.; CHUN-JEN LIU ; Jiang D.D.-S.; Yang P.-C.; Chang S.-C.Journal of the Formosan Medical Association4141
3182001Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequencesCHUN-JEN LIU ; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.Hepatology4646
3192001Molecular cloning and expression of woodchuck granulocyte-macrophage colony stimulating factorWu H.-L.; Chen P.-J.; Lin H.-K.; Lee R.-S.; Lin H.-.; CHUN-JEN LIU ; Lee P.-J.; Lee J.J.; Chen D.-S.Journal of Medical Virology89
3202001Amebic liver abscess and human immunodeficiency virus infection: A report of three casesCHUN-JEN LIU ; Hung C.-C.; Chen M.-Y.; Lai Y.-P.; Chen P.-J.; Huang S.-H.; Chen D.-S.Journal of Clinical Gastroenterology3020
3212000Low incidence of hepatitis C virus transmission between spouses: A prospective studyKao J.-H.; CHUN-JEN LIU ; Chen P.-J.; Chen W.; Lai M.-Y.; Chen D.-S.Journal of Gastroenterology and Hepatology (Australia)5037
3222000Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relativesYu M.-W.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; CHUN-JEN LIU ; Chen P.-J.; Hsiao T.-J.; Lee P.-H.; Chen C.-J.Journal of the National Cancer Institute200182
3232000Interspousal transmission of TT virus: Low efficiency and lack of apparent risk factorsCHUN-JEN LIU ; Kao J.-H.; Chen W.; Tsai R.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.Journal of Gastroenterology and Hepatology (Australia)22
3242000Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinomaYu M.-W.; Cheng S.-W.; Lin M.-W.; Yang S.-Y.; Liaw Y.-F.; Chang H.-C.; Hsiao T.-J.; Lin S.-M.; Lee S.-D.; Chen P.-J.; CHUN-JEN LIU ; Chen C.-J.Journal of the National Cancer Institute126115
3251999Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in TaiwanCHUN-JEN LIU ; Kao J.-H.; Lai M.-Y.; Chen P.-J.; Chu J.-S.; Chen W.; Chen D.-S.Journal of Gastroenterology and Hepatology (Australia)1411
3261997Nonsecreting immunoproliferative small intestinal disease: Report of a caseCHUN-JEN LIU ; Yang P.-M.; Wong J.-M.; Chiang I.-P.; Wang T.-H.; Chen D.-S.Gastroenterological Journal of Taiwan0
3271997Interspousal transmission of GB virus-C/Hepatitis G virus: A comparison with hepatitis C virusKao J.-H.; CHUN-JEN LIU ; Chen P.-J.; Chen W.; Hsiang S.-C.; Lai M.-Y.; Chen D.-S.Journal of Medical Virology33
3281997Benign recurrent intrahepatic cholestasisCHUN-JEN LIU ; Kao J.-H.; Chen P.-J.; Lai M.-Y.; Mao T.-L.; Wang T.-H.; Chen D.-S.Journal of the Formosan Medical Association10
3291990Remission induction of ANLL with low dose cytosine arabinoside combined with retinoic acid.Chen P.M.; Hsieh R.K.; Chuang M.W.; Liu J.H.; Fan S.; CHUN-JEN LIU ; Tzeng C.H.Zhonghua yi xue za zhi = Chinese medical journal; Free China ed00
3301990Gene rearrangement of cutaneous T-cell lymphoma.Fan F.S.; Lin S.H.; Tzeng C.H.; Chuang M.W.; Yang J.H.; Liu J.H.; Hsieh R.K.; CHUN-JEN LIU ; Liu J.M.; Chen M.S.Zhonghua yi xue za zhi Chinese medical journal; Free China ed00
3311990Complications of bone marrow transplantation in Chinese.Chen P.M.; Fan S.; CHUN-JEN LIU ; Hsieh R.K.; Liu J.H.; Chuang M.W.; Liu R.S.; Tzeng C.H.Haematology and blood transfusion30
3321989Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapyTzeng C.-H.; Chen P.-M.; Chuang M.-W.; Liu J.-H.; Hsieh R.-K.; CHUN-JEN LIU ; Fan S.; Chen K.Y.; Yung C.-H.; Wang S.-Y.; Chau W.-K.; Ching K.-N.Chinese Medical Journal (Taipei)40